Attention-deficit/hyperactivity disorder and the menstrual cycle: Theory and evidence

Abstract

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder that exhibits striking sex differences in symptoms, prevalence, and associated problems across development. Etiological factors and mechanisms underlying these sex differences remain one of the most understudied aspects of this disorder. The current paper seeks to provide a novel theoretical framework for understanding this phenomenon by reviewing evidence that females with ADHD may experience a "double whammy" of organizational and activational pubertal hormonal effects. We propose a novel theory of activational effects of cyclical circulating ovarian hormones on ADHD with increasing risk at times of rapid declines in estrogen. These declines may decrease executive function and trait control at two points of the cycle characterized by biphasic affective risk: (1) increases in approach/risk-taking behaviors at mid-cycle (periovulatory) and (2) increases in avoidance/negative affect perimenstrually. Low estrogen and control may then interact with increases in positive and negative affect, respectively, to increase hyperactivity-impulsivity symptoms post-ovulation and inattention symptoms perimenstrually. These interactions may be exacerbated by organizational pubertal effects on relatively overdeveloped limbic circuitry and adolescent-specific social pressures magnified in females with ADHD.

Keywords: ADHD; Activational effects; Affective risk; Menstrual cycle; Ovarian hormones.

Figure 1.. Example of Typical Shifts in Estradiol, Progesterone, and Luteinizing-Hormone in a Regularly-Cycling Adult Female

Note. Progesterone, luteinizing hormone (LH), and estradiol levels measured by daily saliva sample in a representative ovulating female (three-day rolling average calculated per hormone). • Represents first day of menses; † Represents positive ovulation test.